Spero Therapeutics Inc
NASDAQ:SPRO
Spero Therapeutics Inc
NASDAQ:SPRO
Price:
0.7824
USD
0.5%
Market Closed
Market Cap:
42.7m
USD
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
31.7
Current
0.2
Median
3.9
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=31.7
Enterprise Value
/
-33.8m USD
EBITDA
-1.1m USD
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A
You don't have any saved screeners yet
